Study proves Pfizer vaccine can neutralize UK, South Africa virus variants


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Study proves Pfizer vaccine can neutralize UK, South Africa virus variants
Pfizer vaccine update

 The COVID-19 vaccine co-developed by the American pharmaceutical giant Pfizer and the German biotechnology company BioNTech can neutralise variants of the novel coronavirus that were first reported in the UK and South Africa, a new study suggests.
The research, published in the journal Nature Medicine, noted that the vaccine is effective against coronavirus variants carrying the N501Y and E484K mutations.

According to the scientists, including those from the University of Texas in the US, these variants have a substitution of the amino acid building blocks that make up the viral spike protein — the part of the virus which enables it to enter human cells.

They said these mutations in the 501st and 484th positions of the protein’s amino acid molecule chain appeared in the UK and the South African variants, and could potentially increase the affinity of the viral spike for the receptor on the human cell through which the virus enters cells.

In particular, they said the N501Y mutation may also expand the range of hosts the virus can infect to include mice.

In the current study, the scientists, Pei-Yong Shi and his colleagues engineered combinations of mutations found in these circulating variants and tested a panel of human sera from 20 participants.

They said the sera were obtained from their clinical trial of the Pfizer-BioNtech vaccine obtained two or four weeks after immunisation with two doses spaced three weeks apart.

When they tested the serum against the coronavirus strains, the authors found evidence of neutralisation of the mutant viruses by the sera panel, with slight variation. According to the scientists, neutralisation against the E484K mutation was slightly lower than that against the N501Y mutation.

Commenting on the research, virologist Lawrence Young from the University of Warwick in the UK, said the findings confirm previous studies indicating that the Pfizer vaccine is very likely to be effective against the UK variant.

Story Source

PTI

Tags : #Pfizer #PfizerVaccine #BioNTech #BioNTechVaccine #UKVariantCovid #SouthAfricaVariantCovid #UniversityofWarwick

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026